Sedative, hypnotic or anxiolytic use, unspecified with other sedative, hypnotic or anxiolytic-induced disorders
ICD-10 F13.98 is a billable code used to indicate a diagnosis of sedative, hypnotic or anxiolytic use, unspecified with other sedative, hypnotic or anxiolytic-induced disorders.
F13.98 refers to the use of sedative, hypnotic, or anxiolytic substances that leads to unspecified disorders, which may include addiction, withdrawal symptoms, or intoxication. These substances are often prescribed for anxiety, sleep disorders, or other conditions but can lead to misuse and dependency. Patients may present with various symptoms, including cognitive impairment, mood disturbances, and physical health issues. The diagnosis requires a comprehensive assessment of the patient's substance use history, current symptoms, and any co-occurring mental health disorders. Treatment may involve detoxification, counseling, and medication management to address withdrawal symptoms and support recovery. Accurate coding is essential for appropriate treatment planning and reimbursement.
Comprehensive substance use history, treatment plans, and progress notes.
Patients presenting with withdrawal symptoms, seeking detoxification, or requiring medication-assisted treatment.
Ensure documentation reflects the severity of addiction and any co-occurring mental health disorders.
Detailed psychiatric evaluations, treatment plans, and progress notes regarding mental health status.
Patients with anxiety disorders who misuse sedatives or those experiencing mood disturbances due to substance use.
Document any psychiatric evaluations that differentiate between primary mental health disorders and substance-induced conditions.
Used when assessing a patient for sedative use disorder.
Document the assessment findings and treatment recommendations.
Ensure the assessment aligns with addiction medicine protocols.
F13.98 is used for unspecified sedative, hypnotic, or anxiolytic use with other induced disorders, while F13.10 specifically indicates dependence on these substances.
